Ignite Creation Date:
2025-12-24 @ 7:13 PM
Ignite Modification Date:
2025-12-26 @ 2:29 PM
Study NCT ID:
NCT00827203
Status:
SUSPENDED
Last Update Posted:
2009-03-09
First Post:
2009-01-20
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Safety Study to Determine the Maximum Tolerated Dose of Elesclomol Sodium in Patients With Solid Tumors
Sponsor:
Synta Pharmaceuticals Corp.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2009-01
Start Date Type:
None
Primary Completion Date:
2011-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2011-01
Completion Date Type:
ESTIMATED
First Submit Date:
2009-01-20
First Submit QC Date:
None
Study First Post Date:
2009-01-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2009-03-06
Last Update Post Date:
2009-03-09
Last Update Post Date Type:
ESTIMATED